Interferon-alpha affects the tumour necrosis factor-alpha content of mast cells in human nasal mucosa. A pilot study in allergic patients

Italian Journal of Anatomy and Embryology

Volumn 109, Issue 2, 2004, Pages 115-122

  Riccardi Arbi, Rossella ^a   Bacci, Stefane ^a   Romagnoli, Paolo ^a,b   Rucci, Lucio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Sect E Allara   (Italy)

Author keywords

Antigen challenge; Immunohistochemistry; Rhinitis

Indexed keywords

ALLERGEN; ALPHA INTERFERON; AVIDIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLERGY; ANALYSIS OF VARIANCE; ARTICLE; BIOPSY; CELL COUNT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MAST CELL; NOSE MUCOSA; PROTEIN FUNCTION; PROVOCATION TEST; STATISTICAL SIGNIFICANCE;

ADULT; CELL COUNT; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERFERON-ALPHA; MALE; MAST CELLS; MIDDLE AGED; NASAL MUCOSA; PILOT PROJECTS; RHINITIS, ALLERGIC, SEASONAL; SECRETORY VESICLES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4544365192     PISSN: 00040223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Adolf G.R.: (1995) Human Interferon omega - a review. Mult. Scler. 1, S44-S47.
2. Arnaud P.: (2002) The interferons: pharmacology, mechanism of action, tolerance and side effects. Rev. Med. Intern. 4, 449s-458s.
3. Bacci S., Rucci L., Riccardi-Arbi R., and Borghi-Cirri M.B.: (1998) Colocalization of tumor necrosis factor-alpha and nitric oxide-synthase immunoreactivity in mast cell granules of nasal mucosa. Histol. Histopathol. 13, 1011-1014.
4. Beil W.J., Login G.R., Galli S.J., and Dvorak A.M.: (1994) Ultrastructural immunogold localization of tumor necrosis factor alpha to the cytoplasmic granules of rat peritoneal mast cells with rapid microwave fixation. J. Allergy Clin. Immunol. 1, 531-536.
5. Bissonette E.Y., Chin B., and Befus A.D.: (1995) Interferons differentially regulate histamine and TNF-alpha rat intestinal mucosal mast cells. Immunology 86, 12-17.
6. Bradding P., Mediwake R., Feather I.H., Madden J., Church M.K., Holgate S.T., and Howarth P.H.: (1995) TNF-alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin. Exp. All. 25, 406-415.
7. Carswell E.A.., Old L.J., Krassel R.I., Green S., Fiore N., and Williamson B.: (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci USA 72, 3666-3670.
8. Crivellato E., Candussio L., Mallardi F., and Ribatti D. (2002) Recombinant human alpha-2a interferon promotes an atypical process of mast cell secretion with ultrastructural features suggestive for piecemeal degranulation. J. Anat. 201, 507-512.
9. Costa J.J., Matossian K., and Resnick M.B.: (1993) Human eosinophils can express the cytokines tumour necrosis factor alpha and macrophage inflammatory protein 1-alpha. J. Clin. Invest. 91, 2673-2684.
10. Cuturi M.C., Murphy M., Costa-Giomi M.P., Weinmann R., Perussia B., and Trinchieri G.: (1987) Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med. 165, 1581-1594.
11. Dalicik H., Irmak M.K., Ozcan O., Karaoz E., Oztas, E., and Dalcik C.: (1996) Response of the rat mucosal and connective tissue type mast cells to interferon-alpha. Acta Physiol. Pharmacol. Ther. Latinoam. 46, 11-21.
12. Dubravec D.B., Spriggs D.R., Mannick J.A., and Rodrick M.L.: (1990) Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 87, 6758-6761.
13. Enciso J.A., Bissonnette E.Y., and Befus A.D.: (1996) Regulation of mRNA levels of TNF-alpha and the alpha chain of the high-affinity receptor for IgE in mast cell by IFN-gamma and alpha/beta. Int. Arch. Allergy Immunol. 110, 114-123.
14. Gordon J.R., and Galli S.J.: (1990) Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachetin. Nature 346, 274-276.
15. Gurish M.F., and Boyce J.A.: (2002) Mast cell growth, differentiation, and death. Clin. Rev. Allergy Immunol. 22, 107-118.
16. Hauswirth A.W., Simonitsch-Klupp I., Uffmann M., Koller E., Sperr W.R., Lechner K., and Valent P. (2004) Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature. Leuk. Res. 28, 249-257.
17. Higuchi M., Higashi N., Taki H., and Osawa T.: (1990) Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanism of activated macrophages. J. Immunol. 144, 1425-1431.
18. Möller A., and Czarnetzki B.M.: Epidermal cytokines and mast cells. In: Luger T.A., Schwartz T.: Epidermal growth factors and cytokines; Marcel Dekker, New York Basel Hong Kong 1994, 377-394.
19. Mosmann T.R., and Coffman R.L.: (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7, 145-173.
20. Old L.J.: (1988) Tumor necrosis factor. Sci. Amer. 258: 59-60, 69-75.
21. Petska S.: The interferons. In: Luger T.A., Schwartz T.: Epidermal growth factors and cytokines; Marcel Dekker, New York Basel Hong Kong 1994, 457-472.
22. Richards A.L., Okuno T., Takagaki Y., and Dieu J.Y.: (1988) Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF. J. Immunol. 141, 3061-3066.
23. Schernthaner G.H., Spanblochl E., Sperr W.R., Sillaber C., Sempper H., Jurecka W., Hagen W., Wolff K., Chott A., Lechner K., and Valent P.: (2000) Effects of interferon-alpha2beta treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis. Ann. Hematol. 79, 660-666.
24. Schoeler D., Grutzkau A., Henz B.M., Kuchler J., and Kruger-Krasagakis S.: (2003) Interleukin-6 enhances whereas tumor necrosis factor alpha and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins. J. Invest. Dermatol. 120, 795-801
25. Swieter M., Ghali W.A., Rimmer C., and Befus D.: (1989) Interferon-alpha/beta inhibits IgE-dependent histamine release from rat mast cells. Immunology 66, 606-610.
26. Tharp M.D., Seelig L.L., Tigelaar R.E., and Bergstresser P.R.: (1985) Conjugated avidin binds to mast cell granules. J. Histochem. Cytochem. 33, 27-32.
27. Tredget E.E., Shankowsky H.A., Pannu R., Nedelec B., Iwashina T., Ghahary A., Taerum T.V., and Scott P.G. (1998) Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2beta. Plast. Reconstr. Surg. 102, 1317-1328.
28. Valent P., Akin C., Sperr W.R., Escribano L., Arock M., Horny H.P., Bennett J.M., and Metcalfe D.D.: (2003) Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk. Res. 27, 635-641.
29. Van Overveld F.J., Jorens G., Rampart M., De Backer W., and Vermeire P.A. (1991) Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin. Exp. Allergy 21, 711-714.
30. Walsh L.J., Trinchieri G., Waldorf H.A., Whitaker D., and Murphy G.F. (1991) Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. 15, 4220-4224.
31. Wasserman S.I.: The mast cell and the inflammatory response. In: Pepis J., Edwards A.M.: The mast cell its role in health and disease: The Pitman Press, Bath 1985, 457-472.
32. Young J.D., Liu C.C., Butler G., Cohn ZA, and Galli S.J. (1987) Identification, purification and characterization of mast cell associated cytolytic factor related to tumor necrosis factor. Proc. Natl. Acad. Sci. USA 84, 9175-9179.